加拿大癌症行业市场前景及投资研究报告-外文版培训课件

POLITICS

&

SOCIETYCancerinCanadaCHAPTER

01OverviewDistributionoftheleadingcausesofdeathinCanadain2022LeadingcausesofdeathinCanadain2022Shareofdeaths0%5%10%15%20%25%24.7%30%MalignantneoplasmsDiseasesofheart17.2%COVID-195.9%5.5%Accidents(unintentionalinjuries)CerebrovasculardiseasesChroniclowerrespiratorydiseasesDiabetesmellitus4.2%3.7%2.3%1.8%InfluenzaandpneumoniaAlzheimer'sdisease1.6%1.4%1.3%1.1%1.1%ChronicliverdiseaseandcirrhosisNephritis,nephroticsyndromeandnephrosisParkinson'sdiseaseIntentionalself-harm(suicide)3Description:In2022,theleadingcausesofdeathinCanadaweremalignantneoplasms(cancer)anddiseasesoftheheart.Together,thesediseasesaccountedforaround42percentofalldeathsinCanadathatyear.COVID-19wasthethirdleadingcauseofdeathinCanadain2022withalmostsixpercentofdeaths.ReadmoreNote(s):CanadaSource(s):StatCanEstimatednumberofallnewcancercasesinCanadain2023,byageandgender*NumberofCanadiannewcancercasesbyageandgender2023MalesFemales45,00040,00035,00030,00025,00020,00015,00039,40036,20030,90029,60020,80017,70016,90014,3008,90010,0005,2004,7004,4003,9005,00002,2001,450

1,40015-29years5904500-14years30-39years40-49years50-59yearsAgegroup60-69years70-79years80-89years90+years4Description:In2023,itwasestimatedthattherewouldbe1,450newcancercasesamongmalesaged15to29years.CancerisoneoftheleadingcausesofprematuredeathinCanada.ThisstatisticdisplaystheestimatednumberofnewcancercasesinCanadabyagegroupandgenderfor2023.ReadmoreNote(s):Canada;*“Newcases”excludesnon-melanomaskincancer(neoplasms,NOS;epithelialneoplasms,NOS;andbasalandsquamous).

ReadmoreSource(s):StatCanDeathrateformalignantneoplasmsinCanadafrom2001to2022(per100,000population)DeathrateformalignantneoplasmsinCanada2001-2022Deathsper100,000population1000501502002502001200220032004200520062007200820092010201120122013205207.6208.4209.4208.5207.7211.4211.8210.9210.6210.9214213.75Description:In2022,theage-specificmortalityrateofmalignantneoplasmsatallagesinCanadadecreasedbyfivedeaths(-2.31percent)since2021.Thisdecreasewasprecededbyanincreaseinage-specificmortalityrate.

ReadmoreNote(s):Canada;2001to2022;age-standardizedSource(s):StatCanFive-yearrelativesurvivalratioinCanadabyselectcancertypeandgenderfrom2015to2017CancerrelativesurvivalratioinCanadabycancertypeandgender2015-2017SurvivalratioFemales

Males40%

50%0%10%20%30%60%70%80%90%100%110%66%AllcancersThyroid62%98%95%Testis*97%Prostate*Melanoma91%92%86%89%Breast76%86%84%HodgkinlymphomaUterus(body,NOS)*Bladder82%75%77%74%Cervix*73%Kidneyandrenalpelvis73%71%Non–Hodgkinlymphoma68%6Description:From2015to2017,malepatientsinCanadawithHodgkinlymphomahadan84percentchanceofsurvivingfiveyearsafterdiagnosis.Thisstatisticdisplaysthefive-yearsurvivalratioinCanadaforcancer,basedonselectcancertypesandgender,from2015to2017.ReadmoreNote(s):CanadaSource(s):StatCanWaittimesforcancersurgeryinCanadawithin90thpercentilefrom2015to2022,bytypeofsurgery(indays)CancersurgerywaittimesinCanadawithin90thpercentile2015-2023,bytypeBladderBreastColorectalLungProstate145125105856545252015201920202021202220237Description:ThisstatisticdisplaysthewaittimesforcancersurgeryinCanadawithinthe90thpercentile,bycancersite,from2015to2023.In2023,thecolorectalsurgerywaittimeinthecountrywas50daysforthe90thpercentile.Longwaittimescanpreventsickpatientsfromreceivingtimelyhealthcareservices.ReadmoreNote(s):CanadaSource(s):CIHILeading10therapeuticclassesofmedicationsbyshareoftotalspendinginCanadain2022ToptherapeuticclassesbyshareoftotalspendinginCanada2022Percentageoftotalspending0%2%4%6%8%10%12%14%InflammatoryconditionsDiabetes12.7%11.7%Depression5.4%5.3%Asthma/COPDHighbloodpressureCancer4.4%4.4%AttentiondeficithyperactivitydisorderSkinConditions3.8%3.1%2.8%2.8%Ulcer/RefluxCardiovasculardisease8Description:ThisstatisticshowsthetopdrugtherapeuticclassesofmedicationsbyshareoftotalspendinginCanadain2022.Duringthisyear,nearly13percentofoverallspendingwasdonethroughmedicationsforinflammatoryconditionswhilenearly12percentofoverallspendingwasfordiabetes.ReadmoreNote(s):CanadaSource(s):ExpressScriptsInc(Canada)ToptherapeuticclassespurchasedbydrugstoresinCanadain2022(inmillionCanadiandollars)Canadiandrugstores'topdrugtherapeuticclassespurchases2022PurchasesinmillionCanadiandollars1,500

2,00005001,0002,5003,0003,5003,419.93,352.74,000Anti-arthriticsDiabetestherapyImmunologicagentsPsychotherapeuticsOncology2,811.32,708.32,171.8RespiratorytherapyCardiovascularsOphthalmics1,777.81,457.71,407.81,357.3NeurologicaldisordersAnti-virals1,061.99Description:During2022,thetopdrugtherapeuticclassofdrugstorepurchaseswasanti-arthriticmedicationsatsome3.42billionCanadiandollars,followedbydiabetestherapieswith3.35billionCanadiandollarsinpurchases.ThisstatisticshowsthetoptentherapeuticclassesofdrugstorepurchasesinCanadain2022.ReadmoreNote(s):CanadaSource(s):IQVIAPercentageofmedicallyassisteddeathsthatwereattributabletoselectmedicalconditionsinCanadain2022MedicalconditionsassociatedwithmedicallyassisteddeathsinCanada202270%63%60%50%40%30%18.8%20%10%0%14.9%13.2%12.6%10.1%8.2%Cancer-relatedCardiovascularOtherConditionRespiratoryNeurologicalMultipleComorbiditiesOrganFailure10Description:Accordingtothedata,cancer-relatedhealthconditionsweretheleadingmedicalcauseforseekingmedicallyassisteddeath,accountingforabout63percentofmedicallyassisteddeathsin2022.ThisstatisticpresentsthepercentageofmedicallyassisteddeathsattributedtoselectmedicalconditionsinCanadain2022.ReadmoreNote(s):Canada;2022Source(s):HealthCanadaCHAPTER

02IncidenceratesEstimatednumberofnewcancercasesinCanadaasof2023,bytypeNumberofCanadiannewcancercasesbytype2023Numberofnewcases050,000100,000150,000200,000250,000300,000Allcancers*LungandbronchusBreast239,10031,00029,70025,90024,10013,400ProstateColorectalBladderNon-HodgkinlymphomaMelanomaKidneyandrenalpelvisUterus(body,NOS)HeadandneckPancreas10,9009,7008,6008,5007,9007,2006,400Leukemia12Description:Itwasestimatedthatin2023therewouldbeatotalof6,300newcancercasesduetothyroidcancerinCanada.ThisstatisticdisplaystheestimatednumberofnewcancercasesinCanadabycancertype,asof2023.

ReadmoreNote(s):CanadaSource(s):CanadianCancerSociety;CMAJEstimatednumberofnewcancercasesinCanadabytypeandgenderasof2023NumberofCanadiannewcancercasesbytypeandgender2023NumberofnewcasesFemales

Males60,000020,00040,00080,000100,000120,000140,000114,900AllcancersLungandbronchusBreast124,20015,80015,30029,40025,900260ProstateColorectalBladderNon-HodgkinlymphomaMelanomaKidneyandrenalpelvisUterus(body,NOS)HeadandneckPancreas10,60013,5003,20010,2004,7006,1004,1005,6002,9005,6008,5002,1005,8003,2004,00013Description:Itwasestimatedthatin2023therewouldbe1,900newmalecancercasesduetothyroidcancerinCanada.ThisstatisticdisplaystheestimatednumberofnewcancercasesinCanadabycancertypeandgender,asof2023.

ReadmoreNote(s):CanadaSource(s):CanadianCancerSociety;CMAJEstimatedrateofnewcancercasesinCanadaasof2023,bytype(per100,000population)RateofCanadiannewcancercasesbytype2023Casesper100,000population200

3000100400500600Allcancers*513.1LungandbronchusBreast58.968.157.151.1ProstateColorectalBladderNon-HodgkinlymphomaMelanoma25.12424.3KidneyandrenalpelvisUterus(body,NOS)HeadandneckPancreas18.619.616.814.314.3Leukemia14Description:Itwasestimatedthatin2023therewouldbe8.5newstomachcancercasesper100,000populationinCanada.ThisstatisticdepictstheestimatedrateofnewcancercasesinCanadabycancertype,asof2023.

ReadmoreNote(s):CanadaSource(s):CanadianCancerSociety;CMAJEstimatedratesofnewcancercasesinCanadain2023,bytypeandgender(per100,000population)RateofCanadiannewcancercasesbytypeandgender2023Casesper100,000populationFemales

Males3000100200400500600481.2Allcancers*LungandbronchusBreast555.358.460.1129.9120.81.2ProstateColorectalBladderNon-HodgkinlymphomaMelanomaKidneyandrenalpelvisUterus(body,NOS)HeadandneckPancreas42.741.960.511.119.928.820.429.212.225.637.88.825.71216.815Description:In2023,itwasestimatedthattherewouldbe11.7newstomachcancercasesamongmalesinCanadaper100,000population.ThisstatisticdisplaystheestimatedrateofnewcancercasesinCanadabycancertypeandgenderin2023.

ReadmoreNote(s):CanadaSource(s):CanadianCancerSociety;CMAJAge-standardizedcancerincidencerateamongmalesinCanadafrom1988to2023(per100,000population)IncidencerateofcanceramongCanadianmales1988-2023Casesper100,000population300

40001002005006007002023*2022*2021*2020*201920182017201620152014201320122011555.3556556.4557.1548.4557.5562563.3565.1566.1577.9591.861716Description:Thisstatisticdisplaysage-standardizedrateofallcancertypesamongmalesinCanadabetween1988and2019,withaforecastfor2020to2023.In2019,theincidencerateforallcancercasesreached548per100,000populationamongmales.CancerisoneoftheleadingcausesofprematuredeathandalmosthalftheindividualsinCanadawilldevelopthisdiseaseduringtheirlifetime.ReadmoreNote(s):Canada;age-standardizedSource(s):StatCanAge-standardizedcancerincidencerateamongfemalesinCanadafrom1988to2023(per100,000population)IncidencerateofcanceramongCanadianfemales1988-2023Casesper100,000population250

3000501001502003504004505005502023*2022*2021*2020*201920182017201620152014201320122011481.2480.8480.5479.9479.5478.6477.4481.6483.3486.5486.4486.2488.617Description:Thisstatisticdisplaystheage-standardizedrateofallcancercasesamongfemalesinCanadabetween1988and2019,withaforecastfor2020to2023.In2023,theincidencerateforallcancercaseswaspredictedtoreach481per100,000populationamongfemales.CancerisoneoftheleadingcausesofprematuredeathandalmosthalftheindividualsinCanadawilldevelopthisdiseaseduringtheirlifetime.ReadmoreNote(s):Canada;age-standardizedSource(s):StatCanCHAPTER

03DeathsLifetimeprobabilityofdyingfromcanceramongmalesinCanadaasof2020,bytypeLikelihoodofdyingfromcancerinCanadianmalesbytype2020Lifetimeprobability10%0%5%15%20%25%30%AllcancersLungandbronchusProstate24%5%3.3%2.6%ColorectalPancreasBladder1.5%1.1%Non-HodgkinlymphomaLeukemia1%1%Liverandintrahepaticbileduct*Esophagus1%0.9%0.7%0.7%0.7%StomachHeadandneckBrain/CNS19/statistics/438391/likeliness-of-dying-from-cancer-in-canadian-males-by-typeAsof2020,therewasalifetimeprobabilityof0.4percentthatamaleinCanadawoulddiefrommelanomaduringhislifetime.ThisstatisticdisplaysthelifetimeprobabilityofdyingfromcanceramongmalesinCanadabycancertype,asof2020.

ReadmoreNote(s):CanadaSource(s):StatCanLifetimeprobabilityofdyingfromcanceramongfemalesinCanadaasof2020,bytypeLikelihoodofdyingfromcancerinCanadianfemalesbytype2020Lifetimeprobability10%0%5%15%20%25%AllcancersLungandbronchusBreast21%4.8%2.8%2.3%ColorectalPancreas1.5%Ovary1%Non-HodgkinlymphomaLeukemiaUterus(body,NOS)Liverandintrahepaticbileduct*Brain/CNS0.8%0.7%0.7%0.6%0.5%0.4%0.4%StomachBladder20/statistics/438398/likeliness-of-dying-from-cancer-in-canadian-females-by-typeIn2020,therewasalifetimeprobabilityof0.2percentthatafemaleinCanadawoulddiefrommelanomaduringherlifetime.ThisstatisticdepictsthelifetimeprobabilityofdyingfromcanceramongfemalesinCanadabycancertype,asof2020.

ReadmoreNote(s):CanadaSource(s):StatCanEstimatednumberofallcancerdeathsinCanadabyagegroupin2023NumberofCanadiancancerdeathsbyagegroup2023Numberofdeaths05,00010,00015,00020,00025,00030,0000-14years

10015-29years30-39years40-49years50-59years60-69years70-79years80-89years90+years2206702,0006,60018,70027,50022,6008,20021Description:In2023,itwasestimatedthattherewouldbe220deathsduetoallcancersamongthosebetween15and29yearsinCanada.ThisstatisticdisplaystheestimatednumberofdeathsduetoallcancersinCanadabyagegroupin2023.

ReadmoreNote(s):CanadaSource(s):StatCanEstimatednumberofcancerdeathsinCanadabyagegroupandgenderin2023NumberofCanadiancancerdeathsbyagegroupandgender2023MalesFemales18,00016,00014,00012,00010,0008,00015,30012,40012,20010,20010,3008,5006,0004,4003,9004,0003,300

3,30050-59years2,0001,15090029038060401309500-14years15-29years30-39years40-49years60-69years70-79years80-89years90+years22Description:In2023,itwasestimatedthattherewouldbe130deathsduetocanceramongmalesinCanadabetween15to29years.ThisstatisticdisplaystheestimatednumberofdeathsduetoallcancertypesinCanadabyagegroupandgenderin2023.

ReadmoreNote(s):CanadaSource(s):StatCanEstimatedtotalnumberofdeathsduetocancerinCanadain2023,bytypeNumberofCanadiancancerdeathsbytype2023Numberofdeaths30,000

40,000010,00020,00050,00060,00070,00080,00090,000100,000AllcancersLungandbronchusColorectal86,70020,6009,300PancreasBreastProstate5,9005,5004,900Liverandintrahepaticbileduct*Leukemia3,5003,1003,1002,6002,5002,4002,100Non-HodgkinlymphomaBladderBrain/CNSEsophagusHeadandneck23Description:During2023,itwasestimatedthattherewouldbeatotalof1,900deathsduetokidneycancerinCanada.CancerisoneoftheleadingcausesofprematuredeathinCanada.ThisstatisticshowstheestimatedtotalnumberofdeathsduetocancerinCanada.bycancertype,in2023.ReadmoreNote(s):CanadaSource(s):CanadianCancerSociety;CMAJEstimatednumberofdeathsduetocancerinCanadain2023,bytypeandgenderNumberofCanadiancancerdeathsbytypeandgender2023NumberofdeathsFemales

Males15,000

20,00005,00010,00025,00030,00035,00040,00045,00050,00040,200AllcancersLungandbronchusColorectal46,5009,80010,8004,1005,2002,8003,100PancreasBreastProstate5,4004,900551,3002,200Liverandintrahepaticbileduct*Leukemia1,3001,8001,3001,800Non-HodgkinlymphomaBladder7201,8501,0501,450Brain/CNSEsophagus5501,85024Description:During2023,itwasestimatedthattherewouldbe1,250deathsduetokidneycanceramongmalesinCanada.CancerisoneoftheleadingcausesofprematuredeathinCanada.ThisstatisticshowstheestimatednumberofdeathsduetocancerinCanadabycancertypeandgenderin2023.ReadmoreNote(s):CanadaSource(s):CanadianCancerSociety;CMAJEstimatedage-standardizedcancermortalityrateinCanadaasof2023,bytype(per100,000population)MortalityrateinCanadaduetocancerbytype2023Deathsper100,000population60

80

10002040120140160180200AllcancersLungandbronchusColorectal179.741.819.619.2AllothercancersPancreas12.211.9BreastProstateLiverandintrahepaticbileduct*Leukemia9.87.26.46.35.65.25Non-HodgkinlymphomaBrain/CNSBladderEsophagus25Description:In2023,itwasestimatedthattherewouldbefourdeathsper100,000populationduetokidneycancerinCanada.CancerisoneoftheleadingcausesofprematuredeathinCanada.Thisstatisticshowstheestimatedage-standardizedmortalityratesforcancerinCanadabycancertype,asof2023.ReadmoreNote(s):Canada;age-standardizedSource(s):CanadianCancerSociety;CMAJEstimatedage-standardizedcancermortalityratesinCanadaasof2023,bytypeandgender(per100,000population)MortalityrateinCanadaduetocancerbytypeandgender2023Mortalityrateper100,000populationFemalesMales100050150200250154.6AllcancersLungandbronchusColorectal212.336.948.215.724.222.12310.713.9PancreasBreastProstate0.24.94.9Liverandintrahepaticbileduct*Leukemia9.98.34.88.2Non-HodgkinlymphomaBladder2.68.64.5Brain/CNSEsophagus6.82.18.326Description:Itwasestimatedthatin2023therewouldbe5.8deathsper100,000populationduetokidneycanceramongmalesinCanada.Thisstatisticdisplaystheestimatedage-standardizedmortalityratesforcancerinCanadabycancertypeandgender,asof2023.ReadmoreNote(s):Canada;age-standardizedSource(s):CanadianCancerSociety;CMAJCHAPTER

04ProvincesEstimatedcancerincidenceratesinCanadabyprovincein2023(per100,000population)RateofCanadiannewcancercasesbyprovince2023Newcasesper100,000population200

3000100400500600NovaScotiaNewfoundlandandLabradorOntario557546.1534.2NewBrunswickAlberta506504.1496.8496PrinceEdwardIslandManitobaSaskatchewanNorthwestTerritoriesBritishColumbiaNunavut479464.7462.7380.8380Yukon28Description:NovaScotiahasthehighestcancerincidencerateofanyprovinceinCanada,followedbyNewfoundlandandLabrador,andOntario.However,Nunavuthasthehighestcancermortalityrateoftheprovinces.InNunavuttherearearound310deathsfromcancerper100,000population,comparedtoarateof218deathsper100,000inNewfoundlandandLabrador.

ReadmoreNote(s):CanadaSource(s):StatCanEstimatednumberofnewcancercasesinCanadain2023,byprovinceNumberofCanadiannewcancercasesbyprovince2023Numberofnewcases010,00020,00030,00040,00050,00060,00070,00080,00090,000100,00094,100OntarioQuebec59,500BritishColumbiaAlberta30,30023,200Manitoba7,4007,400NovaScotiaSaskatchewan6,200NewBrunswickNewfoundlandandLabradorPrinceEdwardIsland5,5004,0001,06029Description:In2023,itwasestimatedthattherewouldbe6,200newcancercasesinSaskatchewan.ThisstatisticdisplaystheestimatednumberofnewcancercasesinCanadabyprovincefor2023.

ReadmoreNote(s):Source(s):StatCanEstimatednumberofallnewcancercasesinCanadain2023,byprovinceandgenderNumberofCanadiannewcancercasesbyprovinceandgender2023NumberofnewcasesFemales20,000Males05,00010,00015,00014,30025,00030,00035,00040,00045,00050,00055,000BritishColumbiaAlberta16,00011,30011,9003,000SaskatchewanManitoba3,2003,6003,80045,80048,300Ontario28,100Quebec*31,4002,6002,900NewBrunswickNovaScotia3,5003,900510550PrinceEdwardIslandNewfoundlandandLabrador2,0002,00030Description:For2023,itwasestimatedthattherewouldbe3,200newmalecancercasesinSaskatchewan.CancerisoneoftheleadingcausesofprematuredeathinCanada.ThisstatisticdisplaystheestimatednumberofnewcancercasesinCanadabyprovinceandgenderin2023.ReadmoreNote(s):CanadaSource(s):StatCanEstimatedcancermortalityrateinCanadabyprovincein2023(per100,000population)RateofCanadiancancerdeathsbyprovince2023Deathsper100,000population100

150050200250300350NunavutNewfoundlandandLabradorNovaScotia310.3218210.6NorthwestTerritoriesQuebec193.3192.8192.6192.4NewBrunswickManitobaPrinceEdwardIslandSaskatchewanOntario183.5181.6173.2167.2167.1BritishColumbiaAlbertaYukon135.331Description:In2023,itwasestimatedthatthemortalityrateforcancerinManitobawouldbe192.4deathsduetoper100,000population.ThisstatisticdisplaystheestimatedmortalityrateofcancerinCanadabyprovincein2023.

ReadmoreNote(s):CanadaSource(s):StatCanEstimatednumberofcancerdeathsinCanadabyprovincein2023NumberofCanadiancancerdeathsbyprovince2023Numberofdeaths05,00010,00015,00020,00025,00030,00035,00032,200OntarioQuebec22,500BritishColumbiaAlberta11,5007,700NovaScotia2,9502,9502,4502,2501,650ManitobaSaskatchewanNewBrunswickNewfoundlandandLabradorPrinceEdwardIsland42032/statistics/440672/cancer-deaths-in-canada-by-provinceIn2023,itwasestimatedthattherewouldbe2,450cancerdeathsinSaskatchewan.CancerisoneoftheleadingcausesofprematuredeathinCanada.ThisstatisticdisplaystheestimatednumberofdeathsduetocancerinCanadabyprovincein2023.ReadmoreNote(s):CanadaSource(s):StatCanEstimatednumberofcancerdeathsinCanadabyprovinceandgenderin2023NumberofCanadiancancerdeathsbyprovinceandgender2023NumberofdeathsFemales

Males8,000

10,00002,0004,0003,6006,0005,20012,00014,00016,00018,00020,000BritishColumbiaAlberta6,3004,1001,150SaskatchewanManitoba1,3001,4001,55015,000Ontario17,20010,500Quebec12,0001,0501,200NewBrunswickNovaScotia1,3501,600180230PrinceEdwardIslandNewfoundlandandLabrador75090033Description:In2023,itwasestimatedthattherewouldbe1,300deathsduetocanceramongmalesinSaskatchewan.ThisstatisticdisplaystheestimatednumberofcancerdeathsinCanadabyprovinceandgenderin2023.

ReadmoreNote(s):CanadaSource(s):StatCanCHAPTER

05RiskfactorsNumberofCanadiansconsideredheavyalcoholdrinkersfrom2013to2022NumberofCanadianswhowereheavyalcoholdrinkers2013-20227,000,0006,468,6006,015,5005,946,4005,782,8005,770,9005,802,2006,000,0005,000,0004,000,0003,000,0002,000,0001,000,00005,531,6385,320,5005,281,1135,051,000201320142015201620172018201920202021202235Description:In2022,almost6.5millionCanadiansreportedheavydrinkingatleastonceinthepastmonth.ThisstatisticdisplaystheestimatednumberofCanadiansaged12yearsandoverwhoareconsideredheavyalcoholdrinkersfrom2013to2022.

ReadmoreNote(s):Canada;65,000respondents;12yearsandolderSource(s):StatCanPercentageofCanadianadultsthatareoverweightorobesebasedonBMIfrom2015to2022PercentofoverweightorobeseCanadianadultsbasedonBMI2015-2022Overweight36.3%Obese35.8%40%35.8%35.8%36%35.6%35.5%34.7%35%30%25%20%15%10%5%30%29.2%28.2%27.7%26.9%26.8%26.5%26.1%0%2015201620172018201920202021202236Description:In2022,around30percentofadultsaged18yearsandolderinCanadawereobese,while35percentwereoverweight.Althoughthepercentageofoverweightadultsstayedaboutthesamefrom2015to2022,thepercentageofobeseadultsinthesametimeperiodincreasedbyaboutfourpercentagepoints.In2022,therewerearound8.7millionadultsinCanadawhowereobese,whilethenumberofadultswhowereoverweightwasovertenmillion.

ReadmoreNote(s):Canada;2015to2022;65,000respondents;18yearsandolderSource(s):StatCanPercentageofCanadianadolescentsthatareoverweightorobesebasedonBMIfrom2005to2022PercentofoverweightorobeseCanadianadolescentsbasedonBMI2005-20